Vaccine Design
Creative Biolabs offers innovative vaccine design services integrating computational biology, target validation, and advanced antigen display technologies to accelerate vaccine development. Our in silico vaccine design services leverage high-throughput bioinformatics tools and databases to predict T-cell and B-cell epitopes, enabling rational design of immunogenic vaccine components. By analyzing pathogen genomes and host immune responses, we optimize candidate antigens for efficacy while minimizing autoimmunity risks, providing cost-effective and time-saving solutions for early-stage vaccine development. For vaccine target validation, we employ next-generation sequencing (NGS) and functional assays to identify and validate high-priority vaccine targets. Our experts screen thousands of antigen candidates through comparative genomics, proteomics, and epitope prediction, ensuring selected antigens are highly immunogenic, free of human homology, and compatible with diverse pathogens. This rigorous validation process enhances the likelihood of success in preclinical and clinical trials.
Our multiple antigen display technology revolutionizes multivalent vaccine design by using bacterial surface display systems (e.g., autotransporters) and outer membrane vesicles (OMVs) to present multiple antigens simultaneously. This platform ensures high-density antigen display, self-adjuvant effects, and induction of both systemic and mucosal immune responses, making it ideal for combating complex or multi-strain pathogens. With fast production cycles and low costs, it supports the development of vaccines against bacteria, viruses, and beyond.
In Silico Vaccine Design Services: Utilizes computational models and databases to predict epitopes and optimize vaccine components, accelerating candidate selection for infectious diseases.
Vaccine Target Validation Services: Employs NGS and functional assays to identify and validate immunogenic vaccine targets, ensuring specificity and safety for preclinical development.
Multiple Antigen Display Technology for Vaccine Design: Uses bacterial surface display and OMVs to deliver multiple antigens, enabling multivalent vaccine production with enhanced immunogenicity and cost efficiency.
Antibody-Immunostimulant Conjugate Development Services: Preclinical expertise in generating conjugates that deliver immunostimulants to specific targets, enhancing anti-tumor immune responses.
Drive Your Vaccine Project Forward
Whether you need computational vaccine design, target validation, or multivalent antigen display solutions, Creative Biolabs provides tailored expertise to meet your research goals. Our multidisciplinary team combines cutting-edge technology with industry experience to deliver innovative, scalable solutions. Don’t let technical challenges slow your progress–contact us via email or visit our website to discuss how our vaccine design services can accelerate your research and address unmet medical needs.
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
